Antiagregación y anticoagulación, relación con la hemorragia digestiva alta

Wikman Jorgensen, Philip; López Calleja, Eva; Safont Gasó, Pablo; Matarranz del Amo, Mariano; Andrés Navarro, Raquel; Merino Sánchez, Jaime.
Rev. esp. enferm. dig ; 103(7): 360-365, jul. 2011.
Artículo en Español | IBECS (España) | ID: ibc-90592

Documentos relacionados

  1. RHEDAR study: Determination of the risk of gastrointestinal hemorrhage in treatment with dabigatran, acenocoumarol and rivaroxaban.
  2. Surgical management of severe spontaneous hemorrhage of the abdominal wall complicating acenocoumarol treatment.
  3. [Intramural hematoma of the ileum complicating anticoagulant therapy].
  4. Probable interaction between acenocoumarol and levofloxacin: a case series.
  5. Influence of genetic and non-genetic factors on acenocoumarol maintenance dose requirement in a Tunisian population.
  6. [Gastrointestinal lesions and characteristics of acute gastrointestinal bleeding in acenocoumarol-treated patients].
  7. More precise dosing of acenocoumarol for better control in patients aged above 80 years, a randomised controlled pilot study.
  8. Drug-drug interactions between acenocoumarol and proton pump inhibitors in hospitalized patients: Overanticoagulation associated with intravenous omeprazole.
  9. [Spontaneous intramural small bowel hemorrhage: an event on the increase].
  10. [Hemorrhagic complications of chronic anticoagulant treatment in a single intensive care unit].